TCI
>
Innovations
>
Scientific Publications
>
Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial
Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial
Paper Title
Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial
| Ingredient | TCI711 Bacillus coagulans |
|---|---|
| Benefit | Liver Health |
| Study Type | Clinical Trial |
| Journal | Current Developments in Nutrition. 2024; 8: 102083 DOI: 10.1016/j.cdnut.2024.102083 |
* This page summarizes a study published by TCI in a peer-reviewed journal. Please refer to the original journal for full details.